| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | sufentanil (Dzuveo®) |
| Formulation | 30 microgram sublingual tablet |
| Reference number | 3885 |
| Indication | For the management of acute moderate to severe pain in adult patients |
| Company | Aguettant Ltd |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/11/2022 |